Alzheimer's Disease Trial, By Invitation
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People who have been diagnosed with Alzheimer's Disease based on biomarkers, brain imaging, and clinical symptoms.
- People aged between 50 and 85 years old (inclusive), male or female.
- People who have at least one caregiver who is able to live with them for an extended period of time.
- People who do not have severe conditions affecting major organs such as the heart, liver, or kidneys.
- People who are willing to take part in the trial, agree to the surgical treatment plan involved, and sign a consent form.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People whose overall health is poor and who may not be able to tolerate surgery.
- People whose pre-surgery anaesthetic assessment indicates they cannot safely undergo general anaesthesia.
- People who have other neurological or psychiatric conditions in addition to Alzheimer's Disease.
- People who have a serious bleeding tendency due to a blood-clotting disorder.
- People who are unlikely to be able to follow the required treatment schedule and attend follow-up appointments.
- People who have other health conditions that would make tolerating surgery unsafe (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
The assessment of score changes after Lymphaticovenous Anastomosis(LVA) for the treatment of Alzheimer's Disease(AD) using Mini-Mental State Examination(MMSE).
Can't join this trial?
Data last synced from ClinicalTrials.gov: 17 August 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.